APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Drug

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

Selected research

Industry Research

Respiratory Drug Industry Research Report 2026

Report ID 174032380527 December 2025129 pages

Choose your research edition.

Industry ResearchRespiratory Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Respiratory Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.

Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.

Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.

Report Scope

This report quantifies the global Respiratory Drug market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Respiratory Drug Market by Company

GSK

AstraZeneca

Boehringer Ingelheim

Vertex

Roche

Novartis

Teva

Chiesi

Mylan

Sumitomo Dainippon

Merck

Beximco

Respiratory Drug Segment by Type

Inhalable & Nasal Spray

Oral

Others

Respiratory Drug Segment by Application

Hospital

Drugs Store

Respiratory Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Respiratory Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Respiratory Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Respiratory Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Respiratory Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Respiratory Drug Sales (M Units) of Manufacturers (2021-2026) Table 7. Global Respiratory Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Respiratory Drug Revenue of Manufacturers (2021-2026) Table 9. Global Respiratory Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Respiratory Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Respiratory Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Respiratory Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Respiratory Drug, Product Type & Application Table 14. Global Respiratory Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Respiratory Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GSK Company Information Table 19. GSK Business Overview Table 20. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. GSK Respiratory Drug Product Portfolio Table 22. GSK Recent Developments Table 23. AstraZeneca Company Information Table 24. AstraZeneca Business Overview Table 25. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. AstraZeneca Respiratory Drug Product Portfolio Table 27. AstraZeneca Recent Developments Table 28. Boehringer Ingelheim Company Information Table 29. Boehringer Ingelheim Business Overview Table 30. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Boehringer Ingelheim Respiratory Drug Product Portfolio Table 32. Boehringer Ingelheim Recent Developments Table 33. Vertex Company Information Table 34. Vertex Business Overview Table 35. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Vertex Respiratory Drug Product Portfolio Table 37. Vertex Recent Developments Table 38. Roche Company Information Table 39. Roche Business Overview Table 40. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Roche Respiratory Drug Product Portfolio Table 42. Roche Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Novartis Respiratory Drug Product Portfolio Table 47. Novartis Recent Developments Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Teva Respiratory Drug Product Portfolio Table 52. Teva Recent Developments Table 53. Chiesi Company Information Table 54. Chiesi Business Overview Table 55. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Chiesi Respiratory Drug Product Portfolio Table 57. Chiesi Recent Developments Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Mylan Respiratory Drug Product Portfolio Table 62. Mylan Recent Developments Table 63. Sumitomo Dainippon Company Information Table 64. Sumitomo Dainippon Business Overview Table 65. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sumitomo Dainippon Respiratory Drug Product Portfolio Table 67. Sumitomo Dainippon Recent Developments Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck Respiratory Drug Product Portfolio Table 72. Merck Recent Developments Table 73. Beximco Company Information Table 74. Beximco Business Overview Table 75. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Beximco Respiratory Drug Product Portfolio Table 77. Beximco Recent Developments Table 78. Global Respiratory Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Respiratory Drug Sales by Region (2021-2026) & (M Units) Table 80. Global Respiratory Drug Sales Market Share by Region (2021-2026) Table 81. Global Respiratory Drug Sales by Region (2027-2032) & (M Units) Table 82. Global Respiratory Drug Sales Market Share by Region (2027-2032) Table 83. Global Respiratory Drug Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Respiratory Drug Revenue Market Share by Region (2021-2026) Table 85. Global Respiratory Drug Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Respiratory Drug Revenue Market Share by Region (2027-2032) Table 87. North America Respiratory Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 89. North America Respiratory Drug Sales by Country (2027-2032) & (M Units) Table 90. North America Respiratory Drug Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Respiratory Drug Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Respiratory Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 94. Europe Respiratory Drug Sales by Country (2027-2032) & (M Units) Table 95. Europe Respiratory Drug Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Respiratory Drug Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Respiratory Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 99. Asia Pacific Respiratory Drug Sales by Country (2027-2032) & (M Units) Table 100. Asia Pacific Respiratory Drug Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Respiratory Drug Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Respiratory Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 104. South America Respiratory Drug Sales by Country (2027-2032) & (M Units) Table 105. South America Respiratory Drug Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Respiratory Drug Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Respiratory Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 109. Middle East and Africa Respiratory Drug Sales by Country (2027-2032) & (M Units) Table 110. Middle East and Africa Respiratory Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Respiratory Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 113. Global Respiratory Drug Sales by Type (2027-2032) & (M Units) Table 114. Global Respiratory Drug Sales Market Share by Type (2021-2026) Table 115. Global Respiratory Drug Sales Market Share by Type (2027-2032) Table 116. Global Respiratory Drug Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Respiratory Drug Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Respiratory Drug Revenue Market Share by Type (2021-2026) Table 119. Global Respiratory Drug Revenue Market Share by Type (2027-2032) Table 120. Global Respiratory Drug Price by Type (2021-2026) & (US$/Unit) Table 121. Global Respiratory Drug Price by Type (2027-2032) & (US$/Unit) Table 122. Global Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 123. Global Respiratory Drug Sales by Application (2027-2032) & (M Units) Table 124. Global Respiratory Drug Sales Market Share by Application (2021-2026) Table 125. Global Respiratory Drug Sales Market Share by Application (2027-2032) Table 126. Global Respiratory Drug Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Respiratory Drug Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Respiratory Drug Revenue Market Share by Application (2021-2026) Table 129. Global Respiratory Drug Revenue Market Share by Application (2027-2032) Table 130. Global Respiratory Drug Price by Application (2021-2026) & (US$/Unit) Table 131. Global Respiratory Drug Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Respiratory Drug Distributors List Table 135. Respiratory Drug Customers List Table 136. Respiratory Drug Industry Trends Table 137. Respiratory Drug Industry Drivers Table 138. Respiratory Drug Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Respiratory Drug Product Image Figure 5. Global Respiratory Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Respiratory Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Respiratory Drug Sales (2021-2032) & (M Units) Figure 8. Global Respiratory Drug Average Price (US$/Unit) & (2021-2032) Figure 9. Inhalable & Nasal Spray Product Image Figure 10. Oral Product Image Figure 11. Others Product Image Figure 12. Hospital Product Image Figure 13. Drugs Store Product Image Figure 14. Global Respiratory Drug Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Respiratory Drug, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Respiratory Drug Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Respiratory Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Respiratory Drug Sales by Region in 2025 Figure 20. Global Respiratory Drug Revenue by Region in 2025 Figure 21. North America Respiratory Drug Market Size by Country in 2025 Figure 22. North America Respiratory Drug Sales Market Share by Country (2021-2032) Figure 23. North America Respiratory Drug Revenue Market Share by Country (2021-2032) Figure 24. United States Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Respiratory Drug Market Size by Country in 2025 Figure 28. Europe Respiratory Drug Sales Market Share by Country (2021-2032) Figure 29. Europe Respiratory Drug Revenue Market Share by Country (2021-2032) Figure 30. Germany Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Respiratory Drug Market Size by Country in 2025 Figure 41. Asia Pacific Respiratory Drug Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Respiratory Drug Revenue Market Share by Country (2021-2032) Figure 43. China Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Respiratory Drug Market Size by Country in 2025 Figure 52. South America Respiratory Drug Sales Market Share by Country (2021-2032) Figure 53. South America Respiratory Drug Revenue Market Share by Country (2021-2032) Figure 54. Brazil Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Respiratory Drug Market Size by Country in 2025 Figure 58. Middle East and Africa Respiratory Drug Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Respiratory Drug Revenue Market Share by Country (2021-2032) Figure 60. Egypt Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Respiratory Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Respiratory Drug Sales Market Share by Type (2021-2032) Figure 66. Global Respiratory Drug Revenue Market Share by Type (2021-2032) Figure 67. Global Respiratory Drug Price (US$/Unit) by Type (2021-2032) Figure 68. Global Respiratory Drug Sales Market Share by Application (2021-2032) Figure 69. Global Respiratory Drug Revenue Market Share by Application (2021-2032) Figure 70. Global Respiratory Drug Price (US$/Unit) by Application (2021-2032) Figure 71. Respiratory Drug Value Chain Figure 72. Respiratory Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Respiratory Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Inhalable & Nasal Spray
  • Oral
  • Others
Applications
  • Hospital
  • Drugs Store
Companies covered
  • GSK
  • AstraZeneca
  • Boehringer Ingelheim
  • Vertex
  • Roche
  • Novartis
  • Teva
  • Chiesi
  • Mylan
  • Sumitomo Dainippon
  • Merck
  • Beximco

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Respiratory Drug Market Size (2021-2032)
  4. 2.2.2 Global Respiratory Drug Sales (2021-2032)
  5. 2.2.3 Global Respiratory Drug Market Average Price (2021-2032)
  6. 2.3 Respiratory Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Inhalable & Nasal Spray
  9. 2.3.3 Oral
  10. 2.3.4 Others
  11. 2.4 Respiratory Drug by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Drugs Store
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Respiratory Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Respiratory Drug Sales (M Units) of Manufacturers (2021-2026)
  3. 3.3 Global Respiratory Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Respiratory Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Respiratory Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Respiratory Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Respiratory Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Respiratory Drug, Established Date
  9. 3.9 Global Respiratory Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GSK
  2. 4.1.1 GSK Company Information
  3. 4.1.2 GSK Business Overview
  4. 4.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GSK Respiratory Drug Product Portfolio
  6. 4.1.5 GSK Recent Developments
  7. 4.2 AstraZeneca
  8. 4.2.1 AstraZeneca Company Information
  9. 4.2.2 AstraZeneca Business Overview
  10. 4.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 AstraZeneca Respiratory Drug Product Portfolio
  12. 4.2.5 AstraZeneca Recent Developments
  13. 4.3 Boehringer Ingelheim
  14. 4.3.1 Boehringer Ingelheim Company Information
  15. 4.3.2 Boehringer Ingelheim Business Overview
  16. 4.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Boehringer Ingelheim Respiratory Drug Product Portfolio
  18. 4.3.5 Boehringer Ingelheim Recent Developments
  19. 4.4 Vertex
  20. 4.4.1 Vertex Company Information
  21. 4.4.2 Vertex Business Overview
  22. 4.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Vertex Respiratory Drug Product Portfolio
  24. 4.4.5 Vertex Recent Developments
  25. 4.5 Roche
  26. 4.5.1 Roche Company Information
  27. 4.5.2 Roche Business Overview
  28. 4.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Roche Respiratory Drug Product Portfolio
  30. 4.5.5 Roche Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis Respiratory Drug Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Teva
  38. 4.7.1 Teva Company Information
  39. 4.7.2 Teva Business Overview
  40. 4.7.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teva Respiratory Drug Product Portfolio
  42. 4.7.5 Teva Recent Developments
  43. 4.8 Chiesi
  44. 4.8.1 Chiesi Company Information
  45. 4.8.2 Chiesi Business Overview
  46. 4.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Chiesi Respiratory Drug Product Portfolio
  48. 4.8.5 Chiesi Recent Developments
  49. 4.9 Mylan
  50. 4.9.1 Mylan Company Information
  51. 4.9.2 Mylan Business Overview
  52. 4.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mylan Respiratory Drug Product Portfolio
  54. 4.9.5 Mylan Recent Developments
  55. 4.10 Sumitomo Dainippon
  56. 4.10.1 Sumitomo Dainippon Company Information
  57. 4.10.2 Sumitomo Dainippon Business Overview
  58. 4.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sumitomo Dainippon Respiratory Drug Product Portfolio
  60. 4.10.5 Sumitomo Dainippon Recent Developments
  61. 4.11 Merck
  62. 4.11.1 Merck Company Information
  63. 4.11.2 Merck Business Overview
  64. 4.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Merck Respiratory Drug Product Portfolio
  66. 4.11.5 Merck Recent Developments
  67. 4.12 Beximco
  68. 4.12.1 Beximco Company Information
  69. 4.12.2 Beximco Business Overview
  70. 4.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Beximco Respiratory Drug Product Portfolio
  72. 4.12.5 Beximco Recent Developments
5 Global Respiratory Drug Market Scenario by Region
  1. 5.1 Global Respiratory Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Respiratory Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Respiratory Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Respiratory Drug Sales by Region: 2027-2032
  5. 5.3 Global Respiratory Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Respiratory Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Respiratory Drug Revenue by Region: 2027-2032
  8. 5.4 North America Respiratory Drug Market Facts & Figures by Country
  9. 5.4.1 North America Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Respiratory Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Respiratory Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Respiratory Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Respiratory Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Respiratory Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Respiratory Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Respiratory Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Respiratory Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Respiratory Drug Market Facts & Figures by Country
  41. 5.7.1 South America Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Respiratory Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Respiratory Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Respiratory Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Respiratory Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Respiratory Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Respiratory Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Respiratory Drug Sales by Type (2021-2032) & (M Units)
  3. 6.1.2 Global Respiratory Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Respiratory Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Respiratory Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Respiratory Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Respiratory Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Respiratory Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Respiratory Drug Sales by Application (2021-2032) & (M Units)
  3. 7.1.2 Global Respiratory Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Respiratory Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Respiratory Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Respiratory Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Respiratory Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Respiratory Drug Value Chain Analysis
  2. 8.1.1 Respiratory Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Respiratory Drug Production Mode & Process
  5. 8.2 Respiratory Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Respiratory Drug Distributors
  8. 8.2.3 Respiratory Drug Customers
9 Global Respiratory Drug Analyzing Market Dynamics
  1. 9.1 Respiratory Drug Industry Trends
  2. 9.2 Respiratory Drug Industry Drivers
  3. 9.3 Respiratory Drug Industry Opportunities and Challenges
  4. 9.4 Respiratory Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst